TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
SOLS

Solstice Advanced Materials, Inc

Basic Materials · Specialty Chemicals · —

55.50$ +0.3% vs. previous close Closing price · As of: Aug 25, 2026

Statements

Segments

US companies must disclose in their mandatory reports how revenue breaks down across business segments, regions and product lines. We read that breakdown for you straight from the annual and quarterly reports (10-K and 10-Q) of Solstice Advanced Materials, Inc (SOLS). It shows which part of the business is growing — and which one is holding it back.

Revenue by business segment

Revenue by business segment — SOLS
Segment 2023 2024 2025
Refrigerants & Applied Solutions $2.63B 72.0% $2.72B 72.2% · +3.5% $2.79B 71.8% · +2.5%
Electronic & Specialty Materials $1.02B 28.0% $1.05B 27.8% · +2.8% $1.10B 28.2% · +4.6%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Revenue by region

Revenue by region — SOLS
Segment 2023 2024 2025
U.S. Plan $2.21B 60.4% $2.29B 60.6% · +3.6% $2.23B 57.5% · -2.2%
Europe, Middle East and Africa $859.0M 23.5% $886.0M 23.5% · +3.1% $922.0M 23.7% · +4.1%
Other International $585.0M 16.0% $599.0M 15.9% · +2.4% $730.0M 18.8% · +21.9%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Revenue by product line

Revenue by product line — SOLS
Segment 2023 2024 2025
Products $3.42B 93.8% $3.45B 91.6% · +0.8% $3.59B 92.3% · +3.9%
Services $225.0M 6.2% $317.0M 8.4% · +40.9% $299.0M 7.7% · -5.7%

Large figure: segment revenue. Below it the share of revenue in that period and the change against the prior year.

Segment and region names are the ones the company itself uses and are shown as reported. Change and share refer to revenue.

Data as of: August 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Segment figures: SEC EDGAR (10-K/10-Q reports)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?